home Все Новости open_in_new Подробнее

В РФ начали клинические испытания генного препарата от болезни Дюшенна

Миодистрофия Дюшенна — редкое генетическое заболевание, при котором происходит необратимое разрушение мышечных клеток.



The main conceptual idea of the text is that a gene therapy treatment for Duchenne muscular dystrophy is undergoing clinical trials in Russia. This collaboration between "Генериум" and "Сириус" university represents an important step in personalized medicine, aiming to provide a potential cure for this rare and debilitating genetic disease.

today 4 часов назад attach_file Наука
attach_file Разное
attach_file Общество
attach_file Экономика
attach_file События
attach_file Наука
attach_file Общество
attach_file Общество
attach_file Общество
attach_file Общество


ID: 24474915
Add Watch Country

arrow_drop_down